ClinicalTrials.Veeva

Menu

BSGM to Evaluate Patients With GI Symptoms

Children's Hospital of Philadelphia (CHOP) logo

Children's Hospital of Philadelphia (CHOP)

Status

Enrolling

Conditions

Dyspepsia and Other Specified Disorders of Function of Stomach
Gastroparesis
Functional Gastrointestinal Disorders
Gastrointestinal Motility Disorders in Children

Treatments

Device: Body surface gastric mapping device

Study type

Observational

Funder types

Other

Identifiers

NCT05880199
21-018520

Details and patient eligibility

About

The goal of this observational study is to learn about gastric myoelectric activity in children with GI symptoms. The main question it aims to answer is which patterns or signals are associated with GI symptoms as measured by a body surface gastric mapping (BSGM) device. Participants will have their stomach activity recorded for up to 4 hours using the BSGM device and log real-time symptoms. Researchers will compare the recordings of healthy children and children with GI symptoms to define abnormal GI patterns.

Full description

This is an prospective, multi-cohort study that will focus on adaptation and optimization of a novel non-invasive device called 'Body Surface Gastric Mapping (BSGM)' for use in children including defining and optimizing normal ranges in healthy children, defining abnormal patterns in children with GI symptoms, comparing BSGM patterns with currently used diagnostic tests, and evaluating the mechanisms behind current therapeutic interventions using BSGM patterns as biomarkers.

Enrollment

685 estimated patients

Sex

All

Ages

8 to 25 years old

Volunteers

Accepts Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria for Cases

  1. Males or females age 8 to 25 years.

  2. Females ≥11 years of age or who have reached menarche must have a negative urine pregnancy test.

  3. Confirmed diagnosis of a Functional Gastrointestinal and/or Motility Disorder OR undergoing one of the following procedures as part of their clinical care at one of the participating centers:

    1. HRVB
    2. PENFS
    3. ADM
    4. Colonic Manometry
    5. Pyloric Botox
    6. Pyloric Dilation
    7. Gastric Scintigraphy
    8. GES
    9. gammaCore
  4. Those with a body mass index of < 35.

  5. Parental/guardian permission (informed consent) and if appropriate, child assent.

Exclusion Criteria for Cases

  1. History of skin allergies or a history of extreme sensitivity to cosmetics or lotions. Currently open wounds, abrasions, infected or inflamed abdominal skin. (Please note, majority of feeding tubes can be accommodated by the array placement.)
  2. Pregnant women.
  3. Those with any condition, where fasting is not recommended by a physician.
  4. Any allergies to foods that may be present in the standardized meal that cannot be accommodated with an acceptable substitute meal.
  5. Those with physical limitations, who are not able to maintain a relaxed reclined position for the study visit duration.
  6. Those with major developmental delay or cognitive impairment, who are not able to report their symptoms/feelings in the questionnaires.
  7. Those with GI motility disorders that are limited in the esophagus, and the gastric mapping is restricted to capture relevant data based on the investigator's discretion.
  8. Parents/guardians or subjects who, in the opinion of the Investigator, may be non-compliant with study schedules or procedures.

Inclusion Criteria for Controls

  1. Males or females age 8 to 25 years.
  2. Females ≥11 years of age or who have reached menarche must have a negative urine pregnancy test.
  3. Do not have an active Functional Gastrointestinal disorder (FGID) diagnosis and will not be undergoing any procedures outlined in the recruitment plan in the near future.
  4. Those with a body mass index of < 35.
  5. Individuals may include siblings of those with FGIDs.
  6. Parental/guardian permission (informed consent) and if appropriate, child assent.

Exclusion Criteria for Controls

  1. History of skin allergies or a history of extreme sensitivity to cosmetics or lotions. Currently open wounds, abrasions, infected or inflamed abdominal skin.
  2. Pregnant women.
  3. Those with any condition, where fasting is not recommended by a physician.
  4. Allergies to foods that may be included in the standardized meal that cannot be accommodated with an acceptable substitute meal.
  5. Those with physical limitations, who are not able to maintain a relaxed reclined position for the study duration.
  6. Those with major developmental delay or cognitive impairment, who are not able to report their symptoms/feelings in the questionnaires.
  7. Those with GI motility disorders that are limited in the esophagus, and the gastric mapping is restricted to capture relevant data based on the investigator's discretion.
  8. Parents/guardians or subjects who, in the opinion of the Investigator, may be non-compliant with study schedules or procedures.

Trial design

685 participants in 2 patient groups

Children with functional GI disorders
Treatment:
Device: Body surface gastric mapping device
Healthy controls
Treatment:
Device: Body surface gastric mapping device

Trial contacts and locations

4

Loading...

Central trial contact

Hayat Mousa, MD; Alain J Benitez, MD, MSTR

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems